Last reviewed · How we verify

NCT06839651

Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil

Not yet recruiting Phase 1 Last updated 25 February 2025
What this trial tests

Phase 1 trial testing uc-msc secretome intra cavernous injection in Erectile Dysfunctions in 10 participants. Not yet recruiting.

Timeline
21 April 2025
Primary endpoint
1 April 2026
1 April 2026

Quick facts

Lead sponsorIndonesia University
PhasePhase 1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date21 April 2025
Primary completion1 April 2026
Estimated completion1 April 2026

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 40 to 65, male only, with Erectile Dysfunctions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is an experimental pre-post-test design involving 10 patients with severe ED non-responsive to sildenafil. Safety parameters included pain, hematoma, local bleeding, and infection, while efficacy was measured using the IIEF-5 questionnaire, EHS, and morning erection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Erectile Dysfunctions

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06839651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing